1. Home
  2. PICS vs HRMY Comparison

PICS vs HRMY Comparison

Compare PICS & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PICS

PicS N.V. Class A Common Shares

N/A

Current Price

$13.08

Market Cap

1.5B

Sector

Finance

ML Signal

N/A

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$29.38

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PICS
HRMY
Founded
2012
2017
Country
Brazil
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PICS
HRMY
Price
$13.08
$29.38
Analyst Decision
Strong Buy
Buy
Analyst Count
6
10
Target Price
$22.00
$46.70
AVG Volume (30 Days)
702.6K
605.9K
Earning Date
05-30-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.97
EPS
N/A
2.71
Revenue
N/A
$868,453,000.00
Revenue This Year
$29.68
$19.75
Revenue Next Year
$39.06
$12.88
P/E Ratio
$29.44
$10.72
Revenue Growth
N/A
21.51
52 Week Low
$9.88
$25.52
52 Week High
$18.49
$40.87

Technical Indicators

Market Signals
Indicator
PICS
HRMY
Relative Strength Index (RSI) 53.44 56.76
Support Level $10.09 $25.92
Resistance Level $15.33 $30.96
Average True Range (ATR) 0.79 0.82
MACD 0.37 0.42
Stochastic Oscillator 89.54 91.72

Price Performance

Historical Comparison
PICS
HRMY

About PICS PicS N.V. Class A Common Shares

PicS NV is a digital payments company. The company operates a peer-to-peer (P2P) transfer platform that enables individuals to send money via mobile devices. It provides digital wallets, instant payments (Pix), P2P transfers, credit cards, loans, investments, insurance, and SMB payment solutions. The company has four reportable segments: Consumer Banking, Small and Medium-Sized Businesses, Audiences and Ecosystem Integration, and Institutional. The majority of the company's revenue is derived from the Consumer Banking segment, which generates revenue from various transaction activities occurring in the digital wallet, such as Pix, peer-to-peer (P2P) transfers, and bill payments.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: